UnitedHealth Group Incorporated (NYSE:UNH) Position Decreased by My Legacy Advisors LLC

My Legacy Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 4,734 shares of the healthcare conglomerate’s stock after selling 676 shares during the period. UnitedHealth Group accounts for approximately 1.1% of My Legacy Advisors LLC’s holdings, making the stock its 20th biggest position. My Legacy Advisors LLC’s holdings in UnitedHealth Group were worth $2,768,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Sierra Capital LLC increased its stake in UnitedHealth Group by 15.2% in the 3rd quarter. Sierra Capital LLC now owns 4,663 shares of the healthcare conglomerate’s stock worth $2,726,000 after purchasing an additional 616 shares in the last quarter. Signaturefd LLC raised its holdings in shares of UnitedHealth Group by 6.3% during the third quarter. Signaturefd LLC now owns 21,696 shares of the healthcare conglomerate’s stock valued at $12,686,000 after acquiring an additional 1,293 shares during the period. Sequoia Financial Advisors LLC grew its position in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Wooster Corthell Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $205,000. Finally, Harbor Advisory Corp MA acquired a new position in UnitedHealth Group during the third quarter valued at $218,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on UNH shares. Robert W. Baird increased their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, October 16th. Barclays dropped their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday. Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Down 0.3 %

UnitedHealth Group stock opened at $569.98 on Wednesday. The stock has a market cap of $526.33 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The business has a 50 day moving average price of $584.46 and a two-hundred day moving average price of $536.30.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.